Finasteride and Esbriet drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Finasteride (finasteride) and Esbriet (pirfenidone). Common drug interactions include death among females and death among males.
The phase IV clinical study analyzes what interactions people have when they take Finasteride and Esbriet. It is created by eHealthMe based on reports of 269 people who take the same drugs from the FDA, and is updated regularly.
What is Finasteride?
Finasteride has active ingredients of finasteride. It is often used in prostate examination abnormal. eHealthMe is studying from 44,177 Finasteride users. Check the latest studies of Finasteride.
What is Esbriet?
Esbriet has active ingredients of pirfenidone. eHealthMe is studying from 39,858 Esbriet users. Check the latest studies of Esbriet.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
269 people who take Finasteride and Esbriet together, and have interactions are studied.
What are the common drug interactions of Finasteride and Esbriet, by gender? *
What are the common drug interactions of Finasteride and Esbriet, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Finasteride and Esbriet?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Finasteride (44,177 reports)
- Esbriet (39,858 reports)
Browse all drug interactions of Finasteride and Esbriet:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Finasteride:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Esbriet:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Finasteride and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Esbriet and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Fouda AM, Bazeed AM, "Hematuria and Hematospermia Associated with the Use of Finasteride for the Treatment of Androgenic Alopecia: A Case Report", Drug Safety-Case Reports, 2017 Dec .
- Fouda AM, Bazeed AM, "Hematuria and Hematospermia Associated with the Use of Finasteride for the Treatment of Androgenic Alopecia: A Case Report", Drug Safety-Case Reports, 2017 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on finasteride and pirfenidone (the active ingredients of Finasteride and Esbriet, respectively), and Finasteride and Esbriet (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Nicotinic Acid vs. Lovastatin, side effect and effectiveness comparison - 3 seconds ago
- Could Cytarabine cause Subdural Hygroma? - 4 seconds ago
- Could Cytarabine cause Meningioma? - 4 seconds ago
- Could Cytarabine cause Dyspepsia Aggravated? - 4 seconds ago
- Could Savella cause Kidney Infection? - 4 seconds ago
- Toothaches and Cough - 10 seconds ago
- Could Methylphenidate cause Weight Increased? - 18 seconds ago
- Could Yervoy cause Interstitial Nephritis? - 19 seconds ago
- Could Yervoy cause Nephritis - Interstitial? - 19 seconds ago
- Could Nabumetone cause Hair Loss? - 23 seconds ago